Back to search

Article

A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.

2020-10-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Accurate prediction of the prognosis of RCC using a single biomarker is challenging due to the genetic heterogeneity of the disease. However, it is essential to develop an accurate system to allow better patient selection for optimal treatment strategies. ARL4C, ECT2, SOD2 and STEAP3 are novel molecular biomarkers identified in earlier studies as survival-relate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
642048e6-39f5-51f4-a482-d609a551e60d
DOI
10.21203/rs.3.rs-47739/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.DOI 10.21203/rs.3.rs-47739/v2
Select a neighboring publication to make it the new centre.